RxSight, Inc. - SIC # 3850 -

Ticker Exchange SIC # Website Latest Ticker
RXST Nasdaq 3850 www.rxsight.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for RxSight, Inc.

JP Morgan downgrades RxSight on market, competitive pressures - Apr 4th, 2025 3:46 pm
Block upgraded, Nvidia downgraded: Wall Street’s top analyst calls - Apr 4th, 2025 1:40 pm
Is RxSight, Inc. (NASDAQ:RXST) Trading At A 39% Discount? - Apr 4th, 2025 12:53 pm
RxSight Inc (RXST) Q1 2025 Earnings Call Highlights: Strong Year-Over-Year Growth Amid Revised ... - Apr 4th, 2025 7:00 am
Preliminary Q1 2025 Rxsight Inc Earnings Call - Apr 4th, 2025 2:39 am
RxSight Plunges 44% After Slashing 2025 Guidance; Bank of America Downgrades Stock - Apr 3rd, 2025 4:59 pm
RxSight Q1 Revenue Miss, Guidance Cut Raise Growth Concerns, BofA Says - Apr 3rd, 2025 2:58 pm
RxSight Warns On FY25 Revenue As Premium Cataract Market Faces Headwinds, Stock Plunges - Apr 3rd, 2025 11:32 am
RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance - Apr 3rd, 2025 12:00 am
RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference - Mar 25th, 2025 8:05 pm
RxSight, Inc. (NASDAQ:RXST) Just Reported, And Analysts Assigned A US$44.80 Price Target - Feb 28th, 2025 11:29 am
RxSight Full Year 2024 Earnings: EPS Beats Expectations - Feb 27th, 2025 11:27 am
RxSight Inc (RXST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Feb 26th, 2025 7:15 am
RxSight, Inc. (RXST) Misses Q4 Earnings Estimates - Feb 25th, 2025 10:55 pm
RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance - Feb 25th, 2025 9:05 pm
RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025 - Feb 11th, 2025 9:10 pm
Insider Stock Buying Reaches US$1.83m On RxSight - Feb 2nd, 2025 1:49 pm
RxSight price target lowered to $43 from $66 at Needham - Jan 18th, 2025 12:55 pm
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance - Jan 12th, 2025 2:30 pm
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference - Jan 2nd, 2025 9:05 pm